Skip to main navigation
Cue Logo
Skip to Content
Cue Logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Corporate Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Investor Relations

News
Releases

Date Title
Dec 22, 2022
Cue Health Selected by Minnesota Department of Health to Provide Statewide Telehealth to Treatment Services to all Minnesota Residents at No Cost
Nov 17, 2022
Cue Health Announces Appointment of Josh Ghaim, Ph.D. and Sachin Jain, M.D. to its Board of Directors
Nov 09, 2022
Cue Health Reports Third Quarter 2022 Results
Oct 26, 2022
Cue Health to Announce Third Quarter 2022 Financial Results
Oct 06, 2022
Cue Health Partners with Actress Jamie-Lynn Sigler to Raise Awareness of At-Home, Same-Day Test-to-Treatment Platform for COVID-19 and Beyond
Oct 04, 2022
Cue Health Applies with FDA for Emergency Use Authorization of its Cue Flu + COVID‑19 Molecular Test
Sep 27, 2022
Cue Health Appoints Suzanne Stone as New Chief Commercial Officer
Sep 08, 2022
Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer
Sep 01, 2022
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® Flu Molecular Test
Aug 30, 2022
Cue Health to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 38

Shareholder Tools

Print Page Print Page
Email Alerts Email Alerts
RSS RSS
Contact Contact

This website contains depictions of contemplated future products and future care offerings that are still under development by Cue Health and that have not received regulatory authorization, clearance or approval. Currently, the only products authorized for commercial sale in the United States are Cue Health’s COVID-19 tests, which are currently commercially available in the United States pursuant to two Emergency Use Authorizations from the U.S. Food & Drug Administration.

  • © 2023 Cue Health Inc. All rights reserved. Cue and the Cue logo are registered trademarks of Cue Health Inc.